July 31, 2026

News

Contaminated Cannabis Fears Rise Amid DEA Inaction, Research Delays Fuel Criticism

Heather Homer07 mins

A recent report raises serious questions about the effectiveness of the U.S. Drug Enforcement Administration’s (DEA) approach to cannabis, alleging failures that jeopardize public safety in state-regulated markets while simultaneously hindering legitimate pharmaceutical research. The report, attributed to ACCESS Newswire, specifically highlights concerns surrounding the actions, or lack thereof, attributed to DEA Deputy Administrator Thomas…

Read More

Georgia Centralizes Drug Policy: Private Opioid Therapy Banned, State Takes Control

Hank Thompson07 mins

Tbilisi, Georgia — Georgia’s ruling party, Georgian Dream (GD), has enacted sweeping legislative changes that ban private entities from offering opioid replacement therapies and importing or distributing psychotropic drugs. The controversial amendments, passed during an extraordinary session of the GD one-party parliament on July 1-2, transfer the full responsibility for these critical services exclusively to…

Read More

Massachusetts Revokes First Cannabis Testing Lab License Over Public Health Threat, Inaccurate Data

Connor O'Reily07 mins

BOSTON, MA – State regulators in Massachusetts have taken the unprecedented step of revoking the business license for a commercial cannabis testing laboratory, citing a pattern of inaccurate reporting that they deem poses an “immediate and serious threat” to public health and safety. The Massachusetts Cannabis Control Commission (CCC) announced the suspension and subsequent revocation…

Read More

California Cannabis Tax Hikes Again: State Excise Rate Jumps to 19% on July 1, Impacting Consumers and Businesses

Zach Ladelaw08 mins

SACRAMENTO, Calif. – California’s legal cannabis market saw a significant shift beginning July 1, 2025, as the state’s excise tax on all cannabis products climbed from 15% to 19% [8, 14]. This four-percentage-point increase marks another step in the state’s evolving taxation policy for the industry, bringing added costs to consumers and intensifying financial pressures…

Read More

DEA Accused of Sabotaging Medical Cannabis Research Amid Internal Turmoil and Legal Challenges

Sophia Williams07 mins

The U.S. Drug Enforcement Administration (DEA) is reportedly grappling with significant internal and legal challenges, including what some sources describe as a “constitutional crisis” stemming from issues within its Administrative Law Judge (ALJ) system. This comes amid escalating legal action from MMJ BioPharma Cultivation, which alleges the federal agency has deliberately obstructed its crucial medical…

Read More

Thailand Mandates Prescription and Licensing for Cannabis Flower Bud Sales

Naomi Carter09 mins

Bangkok, Thailand – Thailand’s Ministry of Public Health has enacted a significant policy shift regarding cannabis, officially classifying cannabis flower buds as a “controlled herb” under a new ministerial notification. This move, effective June 26, 2025, establishes a stringent regulatory framework requiring official authorization and a valid prescription from licensed medical professionals for the sale…

Read More

Thailand Restricts Cannabis Sales: Prescription Now Required in Major Policy Shift

Maoli Mitchell06 mins

BANGKOK, Thailand – Thailand has implemented a significant policy reversal regarding cannabis, prohibiting sales to individuals without a medical prescription effective Friday, June 27, 2025. This move marks a dramatic shift just three years after the Southeast Asian nation became the first in Asia to decriminalize the plant. The new order, officially signed by Health…

Read More

Thailand Reverses Course on Cannabis, Tightening Rules in Blow to $1 Billion Industry

Malcom Green07 mins

Thailand Reverses Course on Cannabis, Tightening Rules in Blow to $1 Billion Industry Bangkok, Thailand – Just three years after making history as the first country in Southeast Asia to decriminalize cannabis, Thailand’s government has moved decisively to tighten regulations, a move that is sending shockwaves through a nascent industry estimated to be worth $1…

Read More